ConductScience.org, home

Paper39014353

Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.

Liu Y and 8 others. J Nanobiotechnology, 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation. Papers, record 39014353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39014353

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.
PubMed
Journal
J Nanobiotechnology
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.52, provisional
iCite
Revised in PubMed
2024-07-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYe
2Chen XXu
3Chen XXinghao
4Chen JJie
5Zhang HHan
6Xu HHaonan
7Jin LLu
8Wang QQiao
9Tang ZZhan

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SirolimusMajor topic
GelsMajor topic
Animals
Rabbits
Humans
Cornea
Rats
Male
Polysaccharides, Bacterial
Nanoparticles
Administration, Ophthalmic
Corneal Neovascularization
Rats, Sprague-Dawley
Viscosity
Drug Delivery Systems
Ophthalmic Solutions
Cell Line
Biological Availability

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. GF22H128127Basic Public Welfare Research Project of Zhejiang ProvincePubMed
No. YS2022009Special project of Hangzhou Medical CollegePubMed
2019E10021Key Laboratory of Neuropsychiatric Drug Research of Zhejiang ProvincePubMed
2019E10021Key Laboratory of Neuropsychiatric Drug Research of Zhejiang ProvincePubMed
No. 82000864National Natural Science Youth Foundation of ChinaPubMed
No. 2021KY648Science and Technology Project of Medicine and Health of ZhejiangPubMed

Source PubMed

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114727933The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease.Am J Cardiovasc Drugs2003https://conductscience.org/library/papers/14727933PubMed
223716625Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23716625PubMed
330924850Rapamycin Rescues Endoplasmic Reticulum Stress-Induced Dry Eye Syndrome in Mice.Invest Ophthalmol Vis Sci2019https://conductscience.org/library/papers/30924850PubMed
430904549A gellan-based fluid gel carrier to enhance topical spray delivery.Acta Biomater2019https://conductscience.org/library/papers/30904549PubMed
535461804Development of a Thermosensitive In-Situ Gel Formulations of Vancomycin Hydrochloride: Design, Preparation, In Vitro and In Vivo Evaluation.J Pharm Sci2022https://conductscience.org/library/papers/35461804PubMed
621330663The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.Invest Ophthalmol Vis Sci2011https://conductscience.org/library/papers/21330663PubMed
735538191Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.Drug Deliv Transl Res2022https://conductscience.org/library/papers/35538191PubMed
817582643Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery.J Control Release2007https://conductscience.org/library/papers/17582643PubMed
99721433Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.Clin Biochem1998https://conductscience.org/library/papers/9721433PubMed
1033467464Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents.Molecules2021https://conductscience.org/library/papers/33467464PubMed
1132420566Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization.J Mater Chem B2020https://conductscience.org/library/papers/32420566PubMed
1233318177Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/33318177PubMed
1321567404Role of senescent fibroblasts on alkali-induced corneal neovascularization.J Cell Physiol2012https://conductscience.org/library/papers/21567404PubMed
1428433750Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.Eur J Pharm Sci2017https://conductscience.org/library/papers/28433750PubMed
1511165091Solubilization of rapamycin.Int J Pharm2001https://conductscience.org/library/papers/11165091PubMed
1632895514Gelling hypotonic polymer solution for extended topical drug delivery to the eye.Nat Biomed Eng2020https://conductscience.org/library/papers/32895514PubMed
1725667657Preparation of a liposomal delivery system and its in vitro release of rapamycin.Exp Ther Med2015https://conductscience.org/library/papers/25667657PubMed
1825643990Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.Eur J Pharm Biopharm2015https://conductscience.org/library/papers/25643990PubMed
1920202547Keratorefractive effect of microwave keratoplasty on human corneas.J Cataract Refract Surg2010https://conductscience.org/library/papers/20202547PubMed
2012147616Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor.Invest Ophthalmol Vis Sci2002https://conductscience.org/library/papers/12147616PubMed

See all 56 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42835005Microsphere-loaded dual-response in situ gel for enhanced ocular drug delivery.J Pharm Anal2026https://conductscience.org/library/papers/42835005PubMed
42564046Development and characterization of an injectable thermoresponsive PLGA nanoparticle-loaded in situ gel for sustained exemestane delivery.Front Oncol2026https://conductscience.org/library/papers/42564046PubMed
42338899Ion‑Responsive in situ Gel of Quercetin‑Loaded PEGylated Liposomes for Anti‑inflammatory Treatment of Dry Eye Disease.Int J Nanomedicine2026https://conductscience.org/library/papers/42338899PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39014353

GET https://conductscience.org/api/papers/v1/39014353/references?page=2